Clinical Trial Update: Evaluation of Preimplantation Portal Vein and Hepatic Artery Flushing With Tacrolimus [NA]

View source ↗

Summary

A completed clinical trial evaluated tacrolimus flushing for use during liver transplantation to mitigate ischemia-reperfusion injury and early allograft dysfun…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allograft Dysfunction
• Hyperfibrinolysis
• Ischemia-reperfusion Injury
• Liver Transplantation

Drugs mentioned

• Tacrolimus (Tacrolimus)

Snippet

Sponsor: Republican Scientific and Practical Center for Organ and Tissue Transplantation | Conditions: Early Allograft Dysfunction, Ischemic Reperfusion Injury | NA | Status: COMPLETED | Results posted: 2017-02-23